Review Articles

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands;Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands
Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands;Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands
Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
Vol. 102 No. 10 (2017): October, 2017 https://doi.org/10.3324/haematol.2017.164103